These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2509070)

  • 21. [Tuberculosis sequelae: secondary bacterial infections].
    Shishido H; Nagai H; Kurashima A; Yoneda R; Taguchi M; Nagatake T; Matsumoto K
    Kekkaku; 1990 Dec; 65(12):873-80. PubMed ID: 2077264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infections.
    Fass RJ
    Am J Med; 1987 Apr; 82(4A):202-7. PubMed ID: 3555037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Branhamella catarrhalis: an unappreciated pulmonary pathogen.
    Roth RM; Gleckman RA; Hibert DM
    Am Fam Physician; 1984 Oct; 30(4):169-73. PubMed ID: 6333806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation of Moraxella catarrhalis from sputum specimens of Malaysian patients.
    Ahmad N; Cheong YM; Tahir HM
    Malays J Pathol; 1994 Jun; 16(1):63-7. PubMed ID: 16329578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twice daily dosing of erythromycin acistrate in the treatment of acute bronchitis and pneumonia.
    Wiesner B; Wilen-Rosenqvist G; Lehtonen L
    Arzneimittelforschung; 1993 Sep; 43(9):1014-7. PubMed ID: 8240450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenicity of Branhamella catarrhalis.
    Schreiner A
    Acta Otolaryngol Suppl; 1984; 407():40-2. PubMed ID: 6333774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significance of Branhamella catarrhalis in bronchopulmonary infection--a case-control study.
    Yuen KY; Seto WH; Ong SG
    J Infect; 1989 Nov; 19(3):251-6. PubMed ID: 2513358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Branhamella catarrhalis pneumonia.
    Louie MH; Gabay EL; Mathisen GE; Finegold SM
    West J Med; 1983 Jan; 138(1):47-9. PubMed ID: 6837019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Respiratory tract infections: how frequent is antibiotic resistance? In vitro activity of older and recent antibiotics against the significant pathogens].
    Ruckdeschel G
    Fortschr Med; 1994 Nov; 112(33):485-8. PubMed ID: 7843673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Moraxella (Branhamella) catarrhalis: its isolation in the respiratory secretions of adult patients].
    Ferrer Marcellés A; Martínez Ojeda E; Falcó Ferrer V; de la Torre Tejedor E; González Fuente T
    An Med Interna; 1997 Nov; 14(11):554-8. PubMed ID: 9445580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens.
    Braun JM; Beuth J; Blackwell CC; Giersen S; Higgins PG; Tzanakaki G; Unverhau H; Weir DM
    Vaccine; 2004 Feb; 22(7):898-908. PubMed ID: 15040943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections.
    Boyle FM; Georghiou PR; Tilse MH; McCormack JG
    Med J Aust; 1991 May; 154(9):592-6. PubMed ID: 1905385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Branhamella catarrhalis: significance in pulmonary infections and bacteriological features.
    Christensen JJ; Gadeberg O; Bruun B
    Acta Pathol Microbiol Immunol Scand B; 1986 Apr; 94(2):89-95. PubMed ID: 3728028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of amoxicillin and amoxiclav in the therapy of respiratory infections].
    Music E; Kumelj M; Prlja D; Paulin A; Potokar T
    Plucne Bolesti; 1989; 41(3-4):187-92. PubMed ID: 2636405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefaclor treatment of upper and lower respiratory tract infections caused by Moraxella catarrhalis.
    Oberlin JA; Hyslop DL
    Pediatr Infect Dis J; 1990 Jan; 9(1):41-4. PubMed ID: 2105479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with isolation of pathogenic bacteria from sputum of patients with acute bronchospasm.
    Nayyar V; Antonisamy B; John G
    Indian J Chest Dis Allied Sci; 1992; 34(4):197-204. PubMed ID: 1302753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Branhamella catarrhalis as a cause of pneumonia in a patient with miliary tuberculosis.
    Nyong'o AO; Gadberry JL; Silverbrook RM; Silverbrook RM; Kavanaugh CS
    J Am Osteopath Assoc; 1989 May; 89(5):645-50. PubMed ID: 2501241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of a new erythromycin product--eryc--in the treatment of the lower respiratory tract infections.
    Adám A; Kuberka Z
    Ther Hung; 1990; 38(4):152-5. PubMed ID: 2094053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Branhamella infections. An increasingly common respiratory illness.
    Feleke G; Khan FA
    Postgrad Med; 1989 Mar; 85(4):379-86. PubMed ID: 2494649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of isolation of Moraxella catarrhalis in routine cultures from the respiratory tract in adults: antibody response studied in a whole cell EIA.
    Jönsson I; Holme T; Krook A
    Scand J Infect Dis; 1994; 26(5):553-8. PubMed ID: 7855552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.